| News

Artificial Intelligence – the Holy Grail to Healthcare Innovation?

21.06.2018

Last winter, Julia got a cough and a headache. For the third time she went to her physician, who sent her home with painkillers, thinking that it was, after all, just another case of flu. But what if Julia was different from the other flu-stricken patients that the doctor had seen previously? What if her symptoms were those of a rare cancer?

Julia might want to consult a health app for a second opinion. Such AI-driven solutions were presented at the event “DayOne Experts: Artificial Intelligence – The Holy Grail of Healthcare Innovation?” on June 7th which was organized in close partnership with the Life Science Forum Basel at the Biozentrum of the University of Basel.

Dr Martin Hirsch, co-founder of Ada Health, discussed how AI revolutionizes healthcare. Health apps powered by Artificial Intelligence (AI) are now playing Dr. House by tackling health mysteries. They ask a series of questions to patients on how they feel and produce a list of possible diagnoses. Patients can then use this information to solve their ailments themselves or show the results to their doctors to find a treatment.

In an era where medical diagnoses become increasingly personalized, how long will it take us to all have a virtual doctor in the pocket?

Ada-pting to complexity of health

‘Doctors are trained to believe that common things are common,’ explained Dr Hirsch. In traditional consultations, doctors evaluate patients’ symptoms and formulate hypotheses based on experience. Similarly, many health apps rely on machine learning technology for spotting patterns in historical data.

In contrast, Ada’s AI system ‘thinks’ about the symptoms from a set of rules and makes suggestions based on probabilities. This kind of ‘single shot learning’ does not require exposure to large sets of data and is thus valuable for dealing with new situations such as rare diseases.

Ada-mant about benefits to society

If Julia showed Ada’s diagnosis of a rare cancer to her doctor, would he follow up with expensive lab tests, or trust his intuition that it was just a flu? AI technologies can improve the relationship between doctors and patients as patients become more knowledgeable about their health conditions. Further, they would be equipped with ‘conversation starters’ during consultations with their physicians. The results of AI-powered tools should complement human intelligence, not replace it, as Martin Hirsch put it.

AI also changes the health system’s approach to data. A lot of effort currently focuses on enhancing the quantity and quality of ‘big data’ to get better health insights. However, many medical cases are single occurrences that can be missed by big data-driven machine learning. More energy should be spent on improving the rulebook of AI systems, such as adding the genetic data of patients.

Text: Catherine Wu

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Botanikind settles in Basel
Basel Area Business & Innovation, Innovation, Invest

Botanikind settles in Basel

The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for...

Read More
Kinarus secures capital commitment of 57 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Kinarus secures capital commitment of 57 million Swiss francs

The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group...

Read More
Biotech startups from the Basel Area confirm leading position
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Biotech startups from the Basel Area confirm leading position

As part of the Top 100 Swiss Startup Awards 2021, the most promising startups in Switzerland are honored. These also...

Read More
T3 Pharma wins Swiss Economic Award
Basel Area Business & Innovation, Innovation, Invest

T3 Pharma wins Swiss Economic Award

T3 Pharma has won the Swiss Economic Award 2021. Switzerland’s most prestigious young entrepreneur prize is awarded by the Swiss...

Read More
Worg selects Basel Area for European headquarters
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Worg selects Basel Area for European headquarters

Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the Switzerland Innovation Park Basel Area....

Read More
ten23 health settles in Basel
Basel Area Business & Innovation, Innovation, Invest

ten23 health settles in Basel

The life sciences cluster Rosental Mitte located in Basel is home to a new, globally active company called ten23 health....

Read More
Lumineo installs translucent concrete wall for Vinci
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Lumineo installs translucent concrete wall for Vinci

The global construction and energy group Vinci engaged the jurassic Lumineo Group to design a wall made from translucent concrete...

Read More
Roivant invests 200 million dollars in Immunovant
Basel Area Business & Innovation, Innovation, Invest

Roivant invests 200 million dollars in Immunovant

The Basel-based Roivant Group has invested a total of 200 million dollars in the US biopharmaceutical company Immunovant. This investment...

Read More
Lyfegen collaborating with Johnson & Johnson
Basel Area Business & Innovation, Innovation, Invest

Lyfegen collaborating with Johnson & Johnson

The Basel-based startup Lyfegen has developed a platform for value-based healthcare. This should provide improved outcomes for patients and result...

Read More
Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.